Plicated Laparoscopic Adjustable Gastric Banding (Lap Band)

NCT ID: NCT01497028

Last Updated: 2015-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a dual site, prospective study which will compare plicated-Laparoscopic Adjustable Gastric Banding (PLAGB) to standard LABG (SLAGB) to identify significant differences in bariatric surgical outcomes

* Weight Loss
* Co-morbid disease resolution

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Weight Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plicated Gastric Banding

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

Intervention Type PROCEDURE

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

Standard Gastric Banding

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

Intervention Type PROCEDURE

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects must meet the following criteria to be eligible for study entry:

* Age between 18 - 80 years, and
* Severely or Morbidly obese:

* BMI \> 35, or
* BMI \> 30 + co-morbid obesity related disease condition
* Without any contraindications to bariatric surgery, and
* Without any metabolic or medically correctable causes for obesity (eg. Untreated hypothyroidism, Prader-Willi, etc.)
* Patients who have had previous LAGB surgery requiring revision for complications such as slippage, stalled weight loss or weight regain

* Patients with any major medical problems contraindicating surgery
* Patients with a medically treatable cause of obesity (eg. untreated hypothyroidism, Prader-Willi, etc.)
* Patients who elect to undergo a surgery other than a PLAGB or SLAGB
* Pregnant or planning pregnancy within 12 months
* Alcohol or drug addiction
* Established infection anywhere in the body at the time of surgery
* Previous history of other bariatric surgery (except LAGB)
* Family or patient history of autoimmune disease

Exclusion Criteria

Subjects meeting the following criteria will be excluded from study entry:
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jacksonville Surgical Associates

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Robert Cywes, M.D., PhD

Prinicipal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ventura Advanced Surgical Associates

Ventura, California, United States

Site Status

Jacksonville Surgical Associates

Jacksonville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PLAGB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Creating a Laparoscopic Banded Sleeve Gastrectomy
NCT04610099 ACTIVE_NOT_RECRUITING NA
LapBand Adjustment to Improve Early Weight Loss
NCT01060592 COMPLETED PHASE2/PHASE3